2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide

C31H42N12O3 — CID 58152941

IUPAC2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
SMILESCCCCNc1nc(NCCCN(CC)CC)nc(Nc2ccc(/N=N/C(C(C)=O)C(=O)Nc3ccc4[nH]c(=O)[nH]c4c3)cc2)n1
InChIInChI=1S/C31H42N12O3/c1-5-8-16-32-28-38-29(33-17-9-18-43(6-2)7-3)40-30(39-28)35-21-10-12-22(13-11-21)41-42-26(20(4)44)27(45)34-23-14-15-24-25(19-23)37-31(46)36-24/h10-15,19,26H,5-9,16-18H2,1-4H3,(H,34,45)(H2,36,37,46)(H3,32,33,35,38,39,40)/b42-41+
InChIKeySJBWEQKDBIPKCA-WQVHNPAPSA-N
MW630.76 g/mol
LogP4.82
Rot. Bonds18

About 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide

2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide (PubChem CID 58152941) has the molecular formula C31H42N12O3 and a molecular weight of 630.76 g/mol. Its IUPAC name is 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide.

Molecular Properties

Compound Name2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
PubChem CID58152941
Molecular FormulaC31H42N12O3
Molecular Weight630.76 g/mol
Exact Mass630.35
IUPAC Name2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
SMILESCCCCNc1nc(NCCCN(CC)CC)nc(Nc2ccc(/N=N/C(C(C)=O)C(=O)Nc3ccc4[nH]c(=O)[nH]c4c3)cc2)n1
InChIInChI=1S/C31H42N12O3/c1-5-8-16-32-28-38-29(33-17-9-18-43(6-2)7-3)40-30(39-28)35-21-10-12-22(13-11-21)41-42-26(20(4)44)27(45)34-23-14-15-24-25(19-23)37-31(46)36-24/h10-15,19,26H,5-9,16-18H2,1-4H3,(H,34,45)(H2,36,37,46)(H3,32,33,35,38,39,40)/b42-41+
InChIKeySJBWEQKDBIPKCA-WQVHNPAPSA-N
XLogP4.82
TPSA197.54 Ų
H-Bond Donors6
H-Bond Acceptors12
Rotatable Bonds18
Heavy Atoms46
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500630.76
LogP ≤ 54.82
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}

Analyze 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide?
The IUPAC name of 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide (CID 58152941) is 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide.
What is the SMILES notation for 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide?
The canonical SMILES for 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide is CCCCNc1nc(NCCCN(CC)CC)nc(Nc2ccc(/N=N/C(C(C)=O)C(=O)Nc3ccc4[nH]c(=O)[nH]c4c3)cc2)n1.
What is the InChIKey of 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide?
The InChIKey is SJBWEQKDBIPKCA-WQVHNPAPSA-N. The full InChI is InChI=1S/C31H42N12O3/c1-5-8-16-32-28-38-29(33-17-9-18-43(6-2)7-3)40-30(39-28)35-21-10-12-22(13-11-21)41-42-26(20(4)44)27(45)34-23-14-15-24-25(19-23)37-31(46)36-24/h10-15,19,26H,5-9,16-18H2,1-4H3,(H,34,45)(H2,36,37,46)(H3,32,33,35,38,39,40)/b42-41+.
What are the key properties of 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide?
2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide has a molecular weight of 630.76 g/mol, XLogP of 4.82, 18 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[4-[[4-(butylamino)-6-[3-(diethylamino)propylamino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide is sourced from PubChem (CID 58152941), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).